Product Description
Rascase 1.5 Mg injection is a lustrous pharmaceutical innovation, produced through enlightened r-DNA technology to ensure splendiferous efficacy in the treatment of elevated uric acid levels during chemotherapy. This highlighted product is currently offered at the best price, designed for intravenous use, and presented as a single-use, sterile vial containing 1.5 mg of lyophilized powder for easy reconstitution. With its potent Rasburicase composition, Rascase catalyzes uric acid degradation, offering substantive benefits for patients. Maintain storage between 2 to 8C to preserve enzymatic integrity.
Versatile Use & Distinct Advantages of Rascase 1.5 Mg Injection
Rascase 1.5 Mg injection is suitable for patients undergoing chemotherapy who need effective control of high uric acid levels. Its application areas extend to hospitals, oncology clinics, and specialty treatment centers. The primary competitive advantages include single-use sterile packaging, potent enzymatic action, and production by genetic engineering, which ensures consistent efficacy. Its splendiferous effectiveness makes it the highlighted choice for healthcare providers and distributors alike.
Shipping, Packaging & Sampling Details of Rascase 1.5 Mg Injection
Rascase 1.5 Mg injection is shipped goods from India's leading exporter, manufacturer, and supplier network. Each vial is securely packed according to strict standards to preserve quality, and quick dispatch is ensured to meet urgent clinical needs. The list price is competitive, and packaging includes 1.5 mg of lyophilized powder per single-use vial. Samples are available upon request to facilitate enlightened purchasing decisions.
FAQ's of Rascase 1.5 Mg injection:
Q: How is Rascase 1.5 Mg injection used in a clinical setting?
A: Rascase 1.5 Mg injection is administered intravenously after reconstitution, as directed by medical professionals, primarily for managing high uric acid levels in patients undergoing chemotherapy.
Q: What are the primary benefits of using Rascase 1.5 Mg injection?
A: The key benefits include rapid degradation of uric acid due to the action of urate oxidase enzyme Rasburicase, single-use sterile vials, and consistent quality assured by r-DNA technology.
Q: When should Rascase 1.5 Mg injection be administered?
A: This medication is generally used when patients receiving chemotherapy are at risk of developing high uric acid levels, as determined by a healthcare provider.
Q: Where should Rascase 1.5 Mg injection be stored?
A: Store Rascase injection between 2C and 8C to maintain its enzymatic activity and potency.
Q: What makes the packaging of Rascase 1.5 Mg unique?
A: Rascase comes in a highlighted single-use vial, containing a lyophilized powder for intravenous injection, ensuring product sterility and patient safety.
Q: Is sample availability provided for Rascase 1.5 Mg injection?
A: Yes, samples of Rascase 1.5 Mg injection are available upon request to support informed clinical and purchasing decisions.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese